BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2023-01281 A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis clinical trial drugs phase 3 multicentric C Katrin Esther Hostettler Haack Bristol-Myers Squibb Services Unlimited Company Universitätsklinikum Basel, Basel
Universitaetsspital Bern, Bern
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern 31.08.2023
2023-01280 Investigating the temporal dynamics and connectivity patterns underlying conscious perception - an iEEG study with hospitalized patients suffering from epilepsy non clinical, involving persons monocentric A David Pascucci Hôpitaux Universitaires de Genève & UNIGE HUG, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 07.08.2023
2023-01278 Computational fluid dynamics modeling (CFD) of wall shear stress (WSS) of internal carotid artery plaque to predict stroke personal data/biological material monocentric PD Dr.med. David Bervini Universitätsklinik für Neurochirurgie Universitätsklinik für Neurochirurgie, Bern
Kantonale Ethikkommission Bern 06.09.2023
2023-01277 Companion Diagnostic – Measurement of the SRP-9001-104 Phase Ib trial samples with Elecsys® Anti-AAVrh74 antibody immunoassay Trial ID: RD006647

personal data/biological material monocentric Ms Geraldine Peeters Roche Diagnostics Solutions Labcorp, Meyrin
Commission Cantonale d'éthique de la recherche Genève (CCER) 24.07.2023
2023-01276 Effects of Physical exercise timing On strength and Cardiometabolic Health. clinical trial other clinical trials monocentric A Dr. Raphael Knaier University of Basel University of Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 11.08.2023
2023-01274 Project 2011 - ReCare: A prospective observational cohort on high-dose re-irradiation (E2-RADIatE cohort) non clinical, involving persons multicentric A Dr. Matthias Guckenberger EORTC UniversitaetsSpital Zurich, Zurich
Inselspital, Bern
Reseau Hospitalier Neuchatelois - RHNe - La Chaux de Fonds (1462), La Chaux-de-Fonds
Kantonale Ethikkommission Zürich Kantonale Ethikkommission Bern, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 10.10.2023
2023-01273 Electrocardiographic and smartphone photoplethysmographic heart rate variability in depressed patients and healthy individuals: An observational study non clinical, involving persons monocentric A Prof. Dr. med. Sebastian Olbrich Psychiatrische Universitätsklinik Zürich Psychiatric Hospital, University of Zurich, Zürich
Kantonale Ethikkommission Zürich 24.11.2023
2023-01272 Placebo-controlled Investigation of the Acute and Post-acute Effects of Lysergic Acid Diethylamide (LSD) in Healthy Elderly Subjects clinical trial other clinical trials monocentric B Prof. Gregor Hasler Universität Fribourg University of Fribourg, Fribourg
Kantonale Ethikkommission Bern 23.10.2023
2023-01271 Étude qualitative sur les attentes et représentations de patients confrontés aux enjeux de la surmédicalisation non clinical, involving persons monocentric A Dr Gaspard Aebischer Institut universitaire de médecine de famille Institut universitaire de médecine de famille, Genève
Commission Cantonale d'éthique de la recherche Genève (CCER) 10.08.2023
2023-01270 Retrospektive Analyse von Brustgewebe, Brustkrebs, Brustkrebs-Metastasen, sowie des Tumor- und Metastasen-Mikroenvironments bei Brustkrebs-Patientinnen und -Patienten personal data/biological material monocentric Prof. Dr. med. Walter Weber University Hospital Basel University Hospital Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 11.08.2023
2023-01269 Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination with Pembrolizumab Versus Investigator’s Choice in HLA-A*02:01-positive Participants with Previously Treated Advanced Melano More ... clinical trial drugs phase 2 multicentric C Prof. Dr. med. Reinhard Dummer Immunocore, Ltd. Universitätsspital Zürich, Zürich
Kantonsspital St. Gallen, St. Gallen
Kantonale Ethikkommission Zürich Ethikkommission Ostschweiz (EKOS) 13.10.2023
2023-01268 A Phase 1/2 First-in-Human Study of the Safety and Efficacy of IMC-F106C as a Single Agent and in Combination with Checkpoint Inhibitors in HLA-A*02:01-Positive Participants with Advanced PRAME-Positi More ... clinical trial drugs phase 1/2 multicentric C Prof. Dr. med. Reinhard Dummer Immunocore, Ltd. Universitätsspital Zürich, Zürich
Universitätsspital Basel, Basel
University of Lausanne (CHUV), Lausanne
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 09.01.2024
2023-01266 TRI0363 - Evolution of Anti-Drug Responses in XXB750 First in Human Study personal data/biological material monocentric Vanessa Cornacchione, PhD Novartis Pharma AG - NIBR Novartis Pharma AG, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 06.07.2023
2023-01265 BO44426 - A PHASE Ib/II, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE SAFETY, ACTIVITY, AND PHARMACOKINETICS OF DIVARASIB IN COMBINATION WITH OTHER ANTI-CANCER THERAPIES IN PATIENTS WITH PREVIOUSLY UN More ... clinical trial drugs phase 1/2 multicentric C Dr. med. David König Roche Pharma (Schweiz) AG Universitätsspital Basel, Basel
Insel Gruppe AG, Inselspital Bern, Bern
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern 21.09.2023
2023-01264 Computer Navigated Drainage of Rouvière Lymph Node Abscess – Comparison of CAS vs Conventional Technique personal data/biological material monocentric PD Dr. med. Patrick Dubach Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Kopf- und Halschirurgie Inselspital Bern, Klinik für HNO, Kopf- und Halschirurgie, Bern
Kantonale Ethikkommission Bern 05.10.2023
2023-01263 Swiss 2024 Fever Monitoring Study. An investigator initiated double-blinded, randomized controlled multiple crossover superiority trial on continuous fever monitoring with or without fever alerts in p More ... clinical trial other clinical trials monocentric A Dr. Dr. Eva Brack Inselspital Bern Kinderklinik Bern, Inselspital, Bern
Kantonale Ethikkommission Bern 08.09.2023 yes
2023-01262 Regulation of Stress and Early-life Brain Development non clinical, involving persons monocentric A Professor Ulrike Rimmele University of Geneva University of Geneva, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 15.01.2024 yes
2023-01261 Markers for invasive and aggressive behavior in meningiomas personal data/biological material multicentric MD PD MER, Mahmoud Messerer CHUV - NCHD CHUV, Lausanne
Cantonal Hospital Aarau, Aarau
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ 21.08.2023
2023-01260 Gynäkopsychiatrische Begleitung im Übergang zur Elternschaft
– eine Untersuchung bedeutsamer Schutz- und Risikofaktoren unter Einbezug von Partner:innen und interdisziplinärem Netzwerk
non clinical, involving persons monocentric A Dr. phil. Fabienne Forster Psychiatrie St. Gallen Pschiatrie St. Gallen, Wil
Ethikkommission Ostschweiz (EKOS) 26.10.2023
2023-01259 A Phase 3 Randomized, Open-Label, Multicenter Study of Zanubrutinib (BGB-3111) Plus Anti-CD20 Antibodies Versus Lenalidomide Plus Rituximab in Patients With Relapsed/Refractory Follicular or Marginal More ... clinical trial drugs phase 3 multicentric C Dr Gaëlle Rhyner Agocs Beigene Ltd. Hopital Fribourgeois, Fribourg
Réseau hospitalier Neuchatelois, La Chaux-de-Fonds
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 05.03.2024